Adalimumab induced chronic interstitial nephritis: a controlled blinded trial in mice
Journal Title: International Journal of Clinical Rheumatology - Year 2017, Vol 12, Issue 6
Abstract
Background: Adalimumab is a known drug modifying agent for rheumatoid arthritis (RA) and juvenile idiopathic arthritis (JIA) treatment. However little is known about the risk of nephrotoxicity. To determine whether the inhibition of tumor necrosis factor (TNF) binding to cell-surface TNF receptor sites by adalimumab result in acute nephritis in BALB/c mice. Method: Twenty Balb/c mice were studied. Ten mice received subcutaneous (SC) injection of adalimumab (0.0175 mg per 25 kg body weight per 0.03 ml normal saline) biweekly (0, 2, 4, 6 and 8 weeks). For the control group, 10 mice received a SC injection of normal saline (NS) (0.03ml). At the 10th week post injection, the mice were sacrificed, and histopathological studies were conducted. Results: Of the adalimumab-treated group, 4/10 mice died. Kidney histology for the adalimumab-treated group showed that 6/6 displayed histopathological changes manifested as patchy chronic interstitial inflammation with focal tubular epithelial cells vaculation. In contrast, only minimal inflammation was observed in 4/10 mice in the control group (p=0.01). Conclusion: Adalimumab may play a role in inducing chronic interstitial nephritis.
Authors and Affiliations
Sultan M. Al Mogairen
Keywords
Related Articles
- EP ID EP603755
- DOI -
- Views 65
- Downloads 0
Small fiber neuropathy as a part of fibromyalgia or a separate diagnosis?
Fibromyalgia (FM) is a chronic disease characterized mainly by widespread pain, fatigue and cognitive disorders. Small Fiber Neuropathy (SFN) is a generalized sensory nerve disorder with structural and functional nerve a...
Long term follow up of an early oligoarthritis cohort shows that early aggressive intervention leads to drug free remission after 10 years: results from the LOTO study
Objective: To report the long-term outcome in the long-term follow up of the Leeds Early Oligoarthritis Cohort. Methods: Cross-sectional follow up of patients who participated in two previous interventional studies. Subj...
Adalimumab induced chronic interstitial nephritis: a controlled blinded trial in mice
Background: Adalimumab is a known drug modifying agent for rheumatoid arthritis (RA) and juvenile idiopathic arthritis (JIA) treatment. However little is known about the risk of nephrotoxicity. To determine whether the i...
Prevalence of knee pain and its correlates with specific emphasis on CVD risk factors in Hisar urban population
Background: Literature shows osteoarthritis increases the cardiovascular disease related death. There are no such studies from Indian subcontinent that shows association between cardiovascular disease (CVD) risk factors...
Awareness on dietary restriction in case of gout
Gout is a rheumatologically oriented metabolic disease usually occurs due to rise in uric acid in the blood by altering dietary intake. We know gout affects about 1% to 2% of the Western population at some point in their...